<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Calypte Biomedical Corp. | Company News & Executive Profiles - CBMC | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/calypte+biomedical+corp..html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Calypte Biomedical Corp.]]></description>
	<s:counts start="0" returned="10" found="15" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Calypte Biomedical To Hold Investor Call on Tuesday, September 18th To Discuss Significant Corporate Development]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_13/ai_n27373732]]></link>
		<description><![CDATA[LAKE OSWEGO, Ore. -- Calypte Biomedical Corporation (OTCBB: CBMC), a manufacturer and marketer of medical diagnostic tests for the rapid detection of antibodies to the human immunodeficiency virus HIV, announced today that it will hold a conference call for the investment community and other interested parties on Tuesday, September 18,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financing.html"><![CDATA[financing]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Our-Street.com files addendum to complaint with SEC against Calypte Biomedical Corporation.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200311/ai_n19963605]]></link>
		<description><![CDATA[M2 PRESSWIRE-12 November 2003-Our-Street.com: Our-Street.com files  addendum to complaint with SEC against Calypte Biomedical  CorporationC1994-2003 M2 COMMUNICATIONS LTD    RDATE:11122003    Alameda, CA -- Our-Street.com, an Internet-based, public company  watchdog, announced today that it has filed an addendum to the complaint  it...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 12 Nov 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/addendum.html"><![CDATA[addendum]]></category>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Calypte Biomedical Corporation Files Preliminary Proxy Statement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2003_April_4/ai_99623871]]></link>
		<description><![CDATA[Business Editors/Health/Medical Writers  ALAMEDA, Calif.--BUSINESS WIRE--April 4, 2003  Calypte Biomedical Corporation (OTCBB:CALY) today announced that it has filed a preliminary proxy statement with the Securities and Exchange Commission seeking stockholder approval to amend the Company's Amended and Restated Certificate of Incorporation to implement a reverse split of the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 04 Apr 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financing.html"><![CDATA[financing]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Calypte Announces Results of Special Shareholder Meeting and Preliminary Unaudited Fourth Quarter 2002 Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2003_Feb_18/ai_97752691]]></link>
		<description><![CDATA[Business Editors  ALAMEDA, Calif.--BUSINESS WIRE--Feb. 18, 2003  Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA approved serum HIV-1 antibody Western blot supplemental test, announced the results of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 18 Feb 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/shareholder.html"><![CDATA[shareholder]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Calypte Updates Guidance for Current Quarter and 2002; First Quarter Results To Be Released May 1st]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_March_28/ai_84250520]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers  ALAMEDA, Calif.--BW HealthWire--March 28, 2002  Calypte Biomedical Corporation (OTCBB:CALY), a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services, today revised guidance for the first fiscal quarter of 2002 and updated information regarding its financial position. Based...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 28 Mar 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/financing.html"><![CDATA[financing]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/warrant.html"><![CDATA[warrant]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Calypte Biomedical Presents At Wall Street Analyst Forum; Shares plans for future growth with analysts, portfolio managers at key New York conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_Feb_19/ai_83054951]]></link>
		<description><![CDATA[Business/Technology Editors  ALAMEDA, Calif.--BW HealthWire--Feb. 19, 2002  Calypte Biomedical Corporation (OTCBB: CALY), a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services, shared its plans for future growth with several dozen analysts and portfolio managers late last week at The Wall Street...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 19 Feb 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Calypte Biomedical to Present At Wall Street Analyst Forum; Management to Address Analysts, Portfolio Managers On February 14 At Institutional Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_Feb_12/ai_82789078]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers  ALAMEDA, Calif.--BW HealthWire--Feb. 12, 2002  Calypte Biomedical Corporation (OTCBB:CALY), a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services, today announced that its senior management will be making a presentation to analysts and portfolio managers at The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 12 Feb 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/analyst.html"><![CDATA[analyst]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Calypte Announces Preliminary 2001 Operating Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_Feb_7/ai_82593826]]></link>
		<description><![CDATA[Business Editors and Health/Medical Writers  ALAMEDA, Calif.--BW HealthWire--Feb. 7, 2002  Revenues More Than Double and Margins are Sharply Higher,  Setting Quarterly, Annual Records: February 12 Conference  Call-In Numbers Established  Calypte Biomedical Corporation (OTCBB:CALY), a public healthcare company dedicated to the development and commercialization of urine-based...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 07 Feb 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Calypte Announces Extended Expiration Dating for HIV-1 Western Blot Products]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_Nov_29/ai_80416329]]></link>
		<description><![CDATA[Business Editors and Health/Medical Writers  ALAMEDA, Calif.--BW HealthWire--Nov. 29, 2001  Calypte Biomedical Corporation (OTCBB:CALY) today announced that it secured FDA approval for extended dating of its Cambridge HIV-1 Western Blot products from 12 months to 15 months.  Obtaining extended dating was a critical milestone in the Company's...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 29 Nov 2001 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/expiration.html"><![CDATA[expiration]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
	<item>
		<title><![CDATA[Calypte Reports Third Quarter 2001 Financial Results; Revenues Increase 75% Compared With Third Quarter 2000]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_Oct_18/ai_79261276]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers  ALAMEDA, Calif.--BW HealthWire--Oct. 18, 2001  Calypte Biomedical Corporation (OTCBB:CALY) announced today that its revenues for the third quarter ended September 30, 2001 increased 75% to $1,465,000 compared to $835,000 for the same period last year. Revenues for the nine months ended September 30,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 18 Oct 2001 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/calypte+biomedical+corp..html"><![CDATA[Calypte Biomedical Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBMC</category>
		<category domain="tickers">CBMC</category>
	</item>
</channel>
</rss>
